Noveome Biotherapeutics, Inc.

Amendment

CIK: 0001478304·Biotechnology·DELAWARE·Filed: Apr 22, 2019

Total Offering

$15,000,000

Amount Sold

$15,000,000

Investors

39

First Sale

Jan 12, 2018

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Non-Accredited Investors: No

Related Persons

Name	Role
Terence Golden	Related Person
William Golden	Related Person
John McArthur	Related Person
Donald Wagner	Related Person
Robert Langer	Related Person
Patrick Welch	Related Person

Company

Noveome Biotherapeutics, Inc.

100 TECHNOLOGY DRIVE

PITTSBURGH, PA, 15219

412-402-9999

SEC Filing

0001478304-19-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.